BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

369 related articles for article (PubMed ID: 28911083)

  • 21. Multi-cancer analysis of clonality and the timing of systemic spread in paired primary tumors and metastases.
    Hu Z; Li Z; Ma Z; Curtis C
    Nat Genet; 2020 Jul; 52(7):701-708. PubMed ID: 32424352
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Whole exome sequencing reveals intertumor heterogeneity and distinct genetic origins of sporadic synchronous colorectal cancer.
    Di J; Yang H; Jiang B; Wang Z; Ji J; Su X
    Int J Cancer; 2018 Mar; 142(5):927-939. PubMed ID: 29105743
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Exome scale map of genetic alterations promoting metastasis in colorectal cancer.
    Goryca K; Kulecka M; Paziewska A; Dabrowska M; Grzelak M; Skrzypczak M; Ginalski K; Mroz A; Rutkowski A; Paczkowska K; Mikula M; Ostrowski J
    BMC Genet; 2018 Sep; 19(1):85. PubMed ID: 30231850
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Research progress on genetic heterogeneity between primary and paired metastatic colorectal cancer.
    Lu YW; Wang KH
    Yi Chuan; 2017 Jun; 39(6):482-490. PubMed ID: 28903907
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Investigating intra-tumor heterogeneity and expression gradients of miR-21, miR-92a and miR-200c and their potential of predicting lymph node metastases in early colorectal cancer.
    Jepsen RK; Novotny GW; Klarskov LL; Christensen IJ; Høgdall E; Riis LB
    Exp Mol Pathol; 2016 Oct; 101(2):187-196. PubMed ID: 27565378
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Multiregion Genomic Analysis of Serially Transplanted Patient-derived Xenograft Tumors.
    Sato K; Niida A; Masuda T; Shimizu D; Tobo T; Kuroda Y; Eguchi H; Nakagawa T; Suzuki Y; Mimori K
    Cancer Genomics Proteomics; 2019; 16(1):21-27. PubMed ID: 30587497
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Comparative sequence analysis of patient-matched primary colorectal cancer, metastatic, and recurrent metastatic tumors after adjuvant FOLFOX chemotherapy.
    Harada K; Okamoto W; Mimaki S; Kawamoto Y; Bando H; Yamashita R; Yuki S; Yoshino T; Komatsu Y; Ohtsu A; Sakamoto N; Tsuchihara K
    BMC Cancer; 2019 Mar; 19(1):255. PubMed ID: 30898102
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Comparative genomic analysis of primary and synchronous metastatic colorectal cancers.
    Lee SY; Haq F; Kim D; Jun C; Jo HJ; Ahn SM; Lee WS
    PLoS One; 2014; 9(3):e90459. PubMed ID: 24599305
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Latency and interval therapy affect the evolution in metastatic colorectal cancer.
    Nikbakht H; Jessa S; Sukhai MA; Arseneault M; Zhang T; Letourneau L; Thomas M; Bourgey M; Roehrl MHA; Eveleigh R; Chen EX; Krzyzanowska M; Moore MJ; Giesler A; Yu C; Bedard PL; Kamel-Reid S; Majewski J; Siu LL; Riazalhosseini Y; Graham DM
    Sci Rep; 2020 Jan; 10(1):581. PubMed ID: 31953485
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Intratumor heterogeneity and branched evolution revealed by multiregion sequencing.
    Gerlinger M; Rowan AJ; Horswell S; Math M; Larkin J; Endesfelder D; Gronroos E; Martinez P; Matthews N; Stewart A; Tarpey P; Varela I; Phillimore B; Begum S; McDonald NQ; Butler A; Jones D; Raine K; Latimer C; Santos CR; Nohadani M; Eklund AC; Spencer-Dene B; Clark G; Pickering L; Stamp G; Gore M; Szallasi Z; Downward J; Futreal PA; Swanton C
    N Engl J Med; 2012 Mar; 366(10):883-892. PubMed ID: 22397650
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A temporal shift of the evolutionary principle shaping intratumor heterogeneity in colorectal cancer.
    Saito T; Niida A; Uchi R; Hirata H; Komatsu H; Sakimura S; Hayashi S; Nambara S; Kuroda Y; Ito S; Eguchi H; Masuda T; Sugimachi K; Tobo T; Nishida H; Daa T; Chiba K; Shiraishi Y; Yoshizato T; Kodama M; Okimoto T; Mizukami K; Ogawa R; Okamoto K; Shuto M; Fukuda K; Matsui Y; Shimamura T; Hasegawa T; Doki Y; Nagayama S; Yamada K; Kato M; Shibata T; Mori M; Aburatani H; Murakami K; Suzuki Y; Ogawa S; Miyano S; Mimori K
    Nat Commun; 2018 Jul; 9(1):2884. PubMed ID: 30038269
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The Subclonal Architecture of Metastatic Breast Cancer: Results from a Prospective Community-Based Rapid Autopsy Program "CASCADE".
    Savas P; Teo ZL; Lefevre C; Flensburg C; Caramia F; Alsop K; Mansour M; Francis PA; Thorne HA; Silva MJ; Kanu N; Dietzen M; Rowan A; Kschischo M; Fox S; Bowtell DD; Dawson SJ; Speed TP; Swanton C; Loi S
    PLoS Med; 2016 Dec; 13(12):e1002204. PubMed ID: 28027312
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Evolutionary history of metastatic breast cancer reveals minimal seeding from axillary lymph nodes.
    Ullah I; Karthik GM; Alkodsi A; Kjällquist U; Stålhammar G; Lövrot J; Martinez NF; Lagergren J; Hautaniemi S; Hartman J; Bergh J
    J Clin Invest; 2018 Apr; 128(4):1355-1370. PubMed ID: 29480816
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Timing and Origins of Local and Distant Metastases in Lung Cancer.
    Tang WF; Wu M; Bao H; Xu Y; Lin JS; Liang Y; Zhang Y; Chu XP; Qiu ZB; Su J; Zhang JT; Zhang C; Xu FP; Chen JH; Fu R; Chen Y; Yang T; Chen QK; Wu TT; Wu X; Shao Y; Zheng JT; Xie Z; Lv ZY; Dong S; Wu YL; Zhong WZ
    J Thorac Oncol; 2021 Jul; 16(7):1136-1148. PubMed ID: 33722707
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Multiregion ultra-deep sequencing reveals early intermixing and variable levels of intratumoral heterogeneity in colorectal cancer.
    Suzuki Y; Ng SB; Chua C; Leow WQ; Chng J; Liu SY; Ramnarayanan K; Gan A; Ho DL; Ten R; Su Y; Lezhava A; Lai JH; Koh D; Lim KH; Tan P; Rozen SG; Tan IB
    Mol Oncol; 2017 Feb; 11(2):124-139. PubMed ID: 28145097
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Spatial and temporal clonal evolution of intrahepatic cholangiocarcinoma.
    Dong LQ; Shi Y; Ma LJ; Yang LX; Wang XY; Zhang S; Wang ZC; Duan M; Zhang Z; Liu LZ; Zheng BH; Ding ZB; Ke AW; Gao DM; Yuan K; Zhou J; Fan J; Xi R; Gao Q
    J Hepatol; 2018 Jul; 69(1):89-98. PubMed ID: 29551704
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Mutational profile evaluates metastatic capacity of Chinese colorectal cancer patients, revealed by whole-exome sequencing.
    Yang Y; Chen J; Peng H; Xiao Z; Xu W; Zheng M; Li Z; Cao P
    Genomics; 2024 May; 116(3):110809. PubMed ID: 38492821
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Mutational landscape of paired primary and synchronous metastatic lymph node in chemotherapy naive gallbladder cancer.
    Fan B; Xu X; Wang X
    Mol Biol Rep; 2022 Feb; 49(2):1295-1301. PubMed ID: 34988893
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Genetic and microenvironmental intra-tumor heterogeneity impacts colorectal cancer evolution and metastatic development.
    Sobral D; Martins M; Kaplan S; Golkaram M; Salmans M; Khan N; Vijayaraghavan R; Casimiro S; Fernandes A; Borralho P; Ferreira C; Pinto R; Abreu C; Costa AL; Zhang S; Pawlowski T; Godsey J; Mansinho A; Macedo D; Lobo-Martins S; Filipe P; Esteves R; Coutinho J; Costa PM; Ramires A; Aldeia F; Quintela A; So A; Liu L; Grosso AR; Costa L
    Commun Biol; 2022 Sep; 5(1):937. PubMed ID: 36085309
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Quantification of multicellular colonization in tumor metastasis using exome-sequencing data.
    Nishino J; Watanabe S; Miya F; Kamatani T; Sugawara T; Boroevich KA; Tsunoda T
    Int J Cancer; 2020 May; 146(9):2488-2497. PubMed ID: 32020592
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.